- Acorda Therapeutics (NASDAQ:ACOR) is up 10% premarket on robust volume in response to its acquisition of Civitas Therapeutics.
Investors like Acorda's move for Civitas
Recommended For You
More Trending News
About ACOR Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ACOR | - | - |
Acorda Therapeutics, Inc. |